ecotel communication ag First Quarter 2025 Earnings: EPS: €0.07 (vs €0.076 in 1Q 2024)
Net income: €257.5k (down 3.9% from 1Q 2024).
Profit margin: 0.9% (in line with 1Q 2024).
EPS: €0.07 (down from €0.076 in 1Q 2024).
We've discovered 2 warning signs about ecotel communication ag. View them for free.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 2.6% growth forecast for the Telecom industry in Germany.
Performance of the German Telecom industry.
The company's share price is broadly unchanged from a week ago.
We don't want to rain on the parade too much, but we did also find 2 warning signs for ecotel communication ag that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
āshibio licences vantictumab for rare bone disorder
Biotechnology company āshibio has entered an exclusive licencing agreement with Mereo BioPharma for the monoclonal antibody, vantictumab, to treat a rare bone disorder. The agreement aims to facilitate antibody development for the autosomal dominant osteopetrosis type 2 (ADO2) bone condition that currently lacks approved therapies. āshibio will oversee clinical development of vantictumab globally for both adult and paediatric patients. Mereo has granted exclusive rights to āshibio for the development and commercialisation in the US and other regions outside of Europe, where Mereo retains commercial rights. ADO2, also referred to as Albers-Schönberg disease, is a genetic disorder characterised by reduced osteoclast function, leading to dense and brittle bones. It is linked to mutations in the chloride channel 7 (CLCN7) gene, with an incidence rate of one in 20,000 births. Āshibio CEO Pankaj Bhargava stated: 'People living with autosomal dominant osteopetrosis type 2 face a lifetime of bone-related complications resulting in significant morbidity, multiple surgical procedures, chronic pain and impaired quality of life – yet patients have no approved therapy to address the disease. 'Bringing vantictumab into our pipeline reflects our commitment to advancing therapies for rare skeletal conditions and improving the lives of those affected by serious bone disorders.' Vantictumab functions by selectively binding to specific frizzled (Fzd) receptors and inhibiting Wnt (wingless-related integration) signalling pathways. Initially developed for cancer treatment, it has undergone clinical trials in oncology showing a favourable safety and pharmacokinetic profile. Previous studies have generated biomarker data that support the efficacy of vantictumab on osteoclast function, which aids in reducing risks associated with the clinical programme and allows āshibio to expedite the advancement of vantictumab into clinical trials for ADO2. "āshibio licences vantictumab for rare bone disorder" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Yahoo
14 minutes ago
- Yahoo
Baidu misses revenue estimates on online marketing weakness, AI cloud offsets
-- Baidu (HK:9888) (NASDAQ:BIDU) posted mixed results for the second quarter of fiscal 2025, beating profit expectations while revenue missed analysts' estimates. The company's shares rose around 1% in premarket trading Wednesday. The Chinese tech giant posted earnings per share (EPS) of RMB13.58, topping consensus estimates of RMB13.33. Revenue for the three-month period fell 4% year-over-year to RMB32.71 billion, slightly below the consensus of RMB32.92 billion. Baidu (NASDAQ:BIDU) Core contributed RMB26.3 billion ($3.66 billion), down 2% from a year earlier. Online marketing revenue fell 15% to RMB16.2 billion ($2.27 billion), while non-online marketing revenue rose 34% to RMB10.0 billion ($1.40 billion), supported by growth in the AI Cloud business. Revenue at iQIYI came in at RMB6.6 billion ($926 million), marking an 11% year-on-year decline. "In the second quarter, our AI Cloud business continued to deliver robust and healthy revenue growth, supported by our strengthening full-stack AI capabilities and comprehensive end-to-end AI products and solutions," said Robin Li, co-founder and CEO of Baidu. "We remain focused on AI initiatives that offer the greatest long-term value creation potential, where our technology and innovation can make the most meaningful and lasting impact," he added. Baidu's adjusted EBITDA in Q2 totaled RMB6.5 billion ($906 million), with a margin of 20%. Related articles Baidu misses revenue estimates on online marketing weakness, AI cloud offsets Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse Risks Rising? Smart Money Dodged 46%+ Drawdowns on These High-Flying Names Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 minutes ago
- Yahoo
Rising food bills put takeaways on hold
UK consumers are showing clear signs of restraint in their spending habits, with the latest Barclays Consumer Spending Report for July 2025 pointing to a slowdown in fast food and takeaway purchases. Overall spending in the eating and drinking category increased by just 0.8%, while bars, pubs, and clubs saw a 0.4% decline. Takeaway and fast food spending was virtually flat, inching up by only 0.1%, as households prioritise essentials over discretionary treats. Consumers cutting back as budgets tighten The findings underline how deeply the ongoing cost of living crisis continues to shape behaviour. More than half of consumers (51%) told Barclays they intend to cut discretionary spending, with 53% saying they will reduce fast food and takeaway purchases. Dining out is also under pressure, with 54% of people planning to eat at restaurants less often, while 42% are limiting what they spend on drinks at pubs and clubs. For many households, these decisions are not about choice but necessity. Rising rents, higher energy bills, and food price inflation have left little room for non-essential spending. Ordering a pizza or grabbing a quick meal from a fast food outlet is increasingly seen as a luxury rather than a cheap convenience. Grocery prices drive behaviour shifts Grocery inflation has eased slightly in recent months but remains high enough to pressure household budgets. Even small increases in weekly shopping bills force consumers to reconsider their priorities. Shoppers are focusing more on stretching their grocery spend, often opting for supermarket own-label products, discount retailers, and meal planning at home rather than spending on takeaways. This shift highlights how rising grocery costs have a double impact on consumer behaviour. On one hand, families are tightening control over food budgets at supermarkets; on the other, they are cutting back on fast food and dining out to make room for unavoidable grocery expenses. In effect, higher supermarket prices are squeezing discretionary food spend across the board. What retailers can learn from selective spending For retailers, the message is clear: shoppers want value, and they are willing to switch habits to find it. Discount grocers and supermarkets with strong own-label ranges are well placed to capture demand from budget-conscious households. Promotions that focus on meal solutions—such as affordable recipe bundles, family packs, or price-locked staples—can help retailers position themselves as allies in the battle against rising costs. Foodservice operators face a tougher landscape, but opportunities remain for those who can highlight value, convenience, or healthier alternatives. Loyalty schemes, bundled offers, and affordable menu options are likely to resonate most strongly with a cautious consumer base. Looking ahead The Barclays report confirms that fast food spending has stalled as households navigate the ongoing cost of living crisis. High grocery prices are forcing shoppers to think carefully about every pound, reshaping the way they spend on both everyday essentials and occasional treats. For retailers and food operators alike, the challenge is to adapt strategies that balance affordability with quality, helping consumers feel that their money goes further. Those who succeed will be best positioned to weather the selective spending environment and maintain relevance in a cautious market. "Rising food bills put takeaways on hold" was originally created and published by Retail Insight Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio